1. Borchers AT, Lee JL, Gershwin ME,
et al. : Stevens-Johnson syndrome and toxic epidermal necrolysis.
Autoimmun Rev, 7:598-605, 2008.
2. Łoboda J, Dudzik A, Chomyszyn-Gajewska M : Stevens-Johnson syndrome and toxic epidermal necrolysis-based on literature.
Przegl Lek, 72:35-37, 2015.
3. Tristani-Firouzi P, Petersen MJ, Zone JJ,
et al. : Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children.
J Am Acad Dermatol, 47:548-552, 2002.
4. Prins C, Kerdel FA, French LE,
et al. : Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases.
Arch Dermatol, 139:26-32, 2003.
5. Auquier-Dunant A, Mockenhaupt M, Roujeau JC,
et al. : Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Arch Dermatol, 138:1019-24, 2002.
6. Harr T, French LE : Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chem Immunol Allergy, 97:149-166, 2012.
7. KDA Textbook editing board : Dermatology. 5th ed. Ryomoongak, 221-227, 2008.
8. Bajaj N, Madan N, Rathnam A : Cessation in root development: ramifications of 'Stevens-Johnson' syndrome.
J Indian Soc Pedod Prev Dent, 30:267-270, 2012.
9. De Man K : Abnormal root development, probably due to erythema multiforme (Stevens-Johnson syndrome).
Int J Oral Surg, 8:381-385, 1997.
10. Brook U : Stevens-Johnson syndrome and abnormal root development: a case report.
Int J Paediatr Dent, 4:101-103, 1994.
11. LIBRACH IM : Erythema multiforme bullosa (Stevens-Johnson Syndrome); some observations on pathogenesis and on treatment with cortisone and ACTH.
Postgrad Med J, 31:570-574, 1995.
12. Shetty SR, Chatra L, Shenai P, Rao PK : Stevens-Johnson syndrome: a case report.
J Oral Sci, 52:343-346, 2000.
13. Apajalahti S, Hölttä P, Turtola L, Pirinen S : Prevalence of short-root anomaly in healthy young adults.
Acta Odontol Scand, 60:56-9, 2002.
14. Bachot N, Roujeau JC : Differential diagnosis of severe cutaneous drug eruptions.
Am J Clin Dermatol, 4:561-572, 2003.
15. Fritsch PO, Sidoroff A : Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Am J Clin Dermatol, 1:349-360, 2000.
16. Bastuji-Garin S, Rzany B, Roujeau JC,
et al. : Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
Arch Dermatol, 129:92-96, 1993.
17. Assier H, Bastuji-Garin S, Revuz J, Roujeau JC : Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes.
Arch Dermatol, 131:539-543, 1995.
18. Oliveira LR, Zucoloto S : Erythema Multiforme Minor: A Revision.
American Journal of Infectious Disease, 4:224-231, 2008.
19. Del Pozzo-Magana BR, Lazo-Langner A, Rieder MJ, et al. : A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol, 18:121-133, 2011.
20. Bachot N, Revuz J, Roujeau JC : Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression.
Arch Dermatol, 139:33-36, 2003.
21. Huang X, Bringas P Jr, Slavkin HC, Chai Y : Fate of HERS during tooth root development.
Dev Biol, 334:22-30, 2009.
22. Ranalli DN, Elliott MA, Whaley TM, Campagna ED Jr : Stevens-Johnson syndrome: report of case with abnormal root development.
ASDC J Dent Child, 51:298-301, 1984.